Estrella Immunopharma, Inc.

ESLA · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
98
SEC Filings

Business Summary

Estrella Immunopharma, Inc. is a clinical-stage biopharmaceutical company developing T-cell therapies for cancers and autoimmune diseases. The company leverages its proprietary ARTEMIS T Cell Receptor Platform to engineer T cells designed to overcome limitations of traditional CAR-T therapies, such as high toxicity and cost. Its lead product candidate, EB103, is being advanced in conjunction with CF33-CD19t, with manufacturing and R&D support provided by Eureka Therapeutics under a Services Agreement.

Next Earnings

Q2 FY2026 — expected 2026-09-17

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionESLAdiscussed_in_filing Cybersecurity
topic_mentionESLAdiscussed_in_filing Trusted Computing
topic_mentionESLAdiscussed_in_filing Blockchain & Crypto
topic_mentionESLAdiscussed_in_filing Supply Chain
topic_mentionESLAdiscussed_in_filing Regulation
topic_mentionESLAdiscussed_in_filing Healthcare & Bio
topic_mentionESLAdiscussed_in_filing Platform & Ecosystem
topic_mentionESLAdiscussed_in_filing Sovereign & Government
topic_mentionESLAdiscussed_in_filing Cybersecurity
topic_mentionESLAdiscussed_in_filing Trusted Computing
topic_mentionESLAdiscussed_in_filing Blockchain & Crypto
topic_mentionESLAdiscussed_in_filing Supply Chain
topic_mentionESLAdiscussed_in_filing Regulation
topic_mentionESLAdiscussed_in_filing Healthcare & Bio
topic_mentionESLAdiscussed_in_filing Platform & Ecosystem
topic_mentionESLAdiscussed_in_filing Sovereign & Government
topic_mentionESLAdiscussed_in_filing Cybersecurity
topic_mentionESLAdiscussed_in_filing Trusted Computing
topic_mentionESLAdiscussed_in_filing Blockchain & Crypto
topic_mentionESLAdiscussed_in_filing Supply Chain

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-182025-12-310001213900-26-029357EDGAR93K words
2024-09-272024-06-300001213900-24-082374EDGAR—
2023-03-142022-12-310001575872-23-000353EDGAR—
2022-03-292021-12-310001410578-22-000598EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001213900-25-109198EDGAR25K words
2025-08-122025-06-300001213900-25-074567EDGAR—
2025-05-142025-03-310001213900-25-043365EDGAR—
2024-11-142024-09-300001213900-24-098450EDGAR—
2024-05-152024-03-310001213900-24-043126EDGAR—
2024-02-142023-12-310001213900-24-014191EDGAR—
2023-11-202023-09-300001213900-23-088827EDGAR—
2023-08-012023-06-300001213900-23-061563EDGAR—
2023-05-182023-03-310001575872-23-000781EDGAR—
2022-11-142022-09-300001575872-22-001112EDGAR—
2022-08-082022-06-300001410578-22-002124EDGAR—
2022-05-162022-03-310001410578-22-001647EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-01-130001213900-26-003998EDGAR1K words
2026-01-060001213900-26-001777EDGAR—
2025-12-040001213900-25-118097EDGAR—
2025-11-060001213900-25-107249EDGAR—
2025-09-290001213900-25-093197EDGAR—
2025-09-260001213900-25-092471EDGAR—
2025-08-070001213900-25-072746EDGAR—
2025-06-050001213900-25-051361EDGAR—
2025-06-030001213900-25-050329EDGAR—
2025-05-290001213900-25-048597EDGAR—

98 total filings indexed. 72 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Tags

oncology autoimmune-diseases t-cell-therapy car-t-therapy

Company Identity

CIK0001844417
TickerESLA
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 11fd39acb7ea0e8d8d7a88386241041cb41e4fc714abe0852d3f6847ab80e331
parent: c4db14cc553bd10ae27fd72e3dc859db74de08146733f40361b91185905676e5
content hash: 33280d011d74b84e6cca25bf8544223cfca7084979a0149844fe812b50c7805a
signed: 2026-04-13T04:44:54.494Z
sources: 16 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf